KaranSinghDixitMD

Neurology • Chicago, IL

Neurooncology

Physician

Join to view full profile

Dr. Dixit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dixit's full profile

Already have an account?

Office
675 N Saint Clair St
Ste 20-100
Chicago, IL 60611
Phone+1 312-695-4360

Fax+1 312-695-1435

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Neuro-Oncology, 2015 - 2016
University of Illinois College of Medicine at ChicagoChief Residency, Neurology, 2014 - 2015
University of Illinois College of Medicine at ChicagoResidency, Neurology, 2012 - 2015
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2011 - 2012
LSU School of Medicine in ShreveportClass of 2011

Certifications & Licensure

FL State Medical License 2024 - Present
IL State Medical License 2015 - 2026
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial Design.
Rupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, Can Ilgin, Manmeet S Ahluwalia
Neuro-Oncology. 2025-01-14
Dual TERT promoter mutations in an oligodendroglioma, IDH-mutant, 1p/19q co-deleted.
Michael S Fernandopulle, Zachary Cotty-Fattal, Heather Smith, Melissa Mejia Bautista, Jared T Ahrendsen
Journal of Neuropathology and Experimental Neurology. 2025-01-11
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects.
Bobak F Khalili, Tobias Walbert, Craig Horbinski, Karan Dixit, Kapil Gururangan
Future Oncology. 2025-01-09

Press Mentions

Organisations Turn to UiPath’s RPA to Respond to COVID-19April 8th, 2020
Critical MassJanuary 2nd, 2019
Experimental Drug Shows Early Promise for Rare, Incurable Brain TumorsMarch 12th, 2024